INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $104,325 | -41.8% | 127,226 | +7.8% | 0.00% | – |
| Q4 2022 | $179,360 | -18.8% | 118,000 | -7.8% | 0.00% | -100.0% |
| Q3 2022 | $221,000 | +0.9% | 128,049 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $219,000 | +36.0% | 126,500 | +182.1% | 0.00% | 0.0% |
| Q1 2022 | $161,000 | -22.6% | 44,845 | +12.3% | 0.00% | 0.0% |
| Q4 2021 | $208,000 | -35.6% | 39,948 | -11.4% | 0.00% | -50.0% |
| Q3 2021 | $323,000 | -22.7% | 45,067 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $418,000 | +40.3% | 45,067 | +40.5% | 0.00% | 0.0% |
| Q1 2021 | $298,000 | +53.6% | 32,073 | +46.3% | 0.00% | 0.0% |
| Q4 2020 | $194,000 | +26.0% | 21,919 | +64.9% | 0.00% | +100.0% |
| Q3 2020 | $154,000 | -56.6% | 13,296 | +1.1% | 0.00% | -75.0% |
| Q2 2020 | $355,000 | +327.7% | 13,155 | -67.5% | 0.00% | +300.0% |
| Q3 2019 | $83,000 | -19.4% | 40,478 | +15.0% | 0.00% | -50.0% |
| Q2 2019 | $103,000 | -12.7% | 35,193 | +11.7% | 0.00% | 0.0% |
| Q1 2019 | $118,000 | -4.1% | 31,514 | +9.3% | 0.00% | -33.3% |
| Q4 2018 | $123,000 | -16.9% | 28,837 | +8.4% | 0.00% | 0.0% |
| Q3 2018 | $148,000 | – | 26,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |